What is Sidoti’s Estimate for PRE Q2 Earnings?

Prenetics Global Limited (NASDAQ:PREFree Report) – Equities researchers at Sidoti issued their Q2 2026 earnings per share (EPS) estimates for shares of Prenetics Global in a report released on Monday, June 22nd. Sidoti analyst A. Hantman anticipates that the company will post earnings per share of ($0.91) for the quarter. The consensus estimate for Prenetics Global’s current full-year earnings is ($1.03) per share. Sidoti also issued estimates for Prenetics Global’s FY2026 earnings at ($2.12) EPS.

Prenetics Global (NASDAQ:PREGet Free Report) last announced its quarterly earnings data on Wednesday, June 10th. The company reported ($0.56) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.07). Prenetics Global had a negative net margin of 62.45% and a negative return on equity of 20.33%. The firm had revenue of $35.95 million during the quarter, compared to the consensus estimate of $36.00 million.

A number of other research analysts have also weighed in on PRE. Lake Street Capital assumed coverage on Prenetics Global in a report on Monday, March 16th. They set a “buy” rating and a $29.00 target price for the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Prenetics Global in a report on Tuesday, April 21st. Finally, Benchmark started coverage on Prenetics Global in a report on Tuesday, June 16th. They set a “buy” rating and a $30.00 price objective on the stock. Four analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $31.75.

View Our Latest Stock Report on Prenetics Global

Prenetics Global Price Performance

Shares of PRE stock opened at $19.72 on Thursday. Prenetics Global has a 1 year low of $7.18 and a 1 year high of $23.63. The stock has a market capitalization of $332.68 million, a price-to-earnings ratio of -4.31 and a beta of 0.24. The company’s fifty day simple moving average is $18.44 and its two-hundred day simple moving average is $18.21.

Institutional Investors Weigh In On Prenetics Global

Large investors have recently made changes to their positions in the business. State of Wyoming purchased a new position in Prenetics Global during the 1st quarter valued at $48,000. Wells Fargo & Company MN purchased a new position in shares of Prenetics Global during the fourth quarter valued at approximately $47,000. JPMorgan Chase & Co. bought a new stake in Prenetics Global in the third quarter worth $65,000. Manatuck Hill Partners LLC bought a new position in Prenetics Global in the 4th quarter worth about $170,000. Finally, T3 Companies LLC purchased a new stake in shares of Prenetics Global during the fourth quarter valued at approximately $170,000. 25.01% of the stock is currently owned by institutional investors.

Prenetics Global announced that its board has approved a share buyback program on Friday, March 6th that allows the company to repurchase $40.00 million in shares. This repurchase authorization allows the company to buy up to 15.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

About Prenetics Global

(Get Free Report)

Prenetics Global (NASDAQ: PRE) is a molecular diagnostics and genetic testing company that delivers a broad range of laboratory and at-home testing solutions. The company’s core offerings include next-generation sequencing (NGS) panels for hereditary health risks, pharmacogenomic reports to guide medication choices, and comprehensive consumer DNA testing services. In addition to genetic insights, Prenetics provides infectious disease diagnostics—most notably real-time PCR testing for pathogens such as SARS-CoV-2—through an integrated platform that combines sample collection, laboratory processing and digital reporting.

Serving both business-to-consumer and business-to-business markets, Prenetics operates a network of laboratories and service centers across Asia Pacific, Europe, the Middle East and North America.

Read More

Earnings History and Estimates for Prenetics Global (NASDAQ:PRE)

Receive News & Ratings for Prenetics Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prenetics Global and related companies with MarketBeat.com's FREE daily email newsletter.